SCHEMBL1680576

SCHEMBL1680576

O=C(NCc1cccc(Oc2ccccc2)c1)Oc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
HTT P42858 1/20 0.58
FFAR1 O14842 5/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
EPHX1 P07099 2/20 0.54
MAPK14 Q16539 1/20 0.54
GNA15 P30679 1/20 0.53
PTGER3 P43115 1/20 0.53
FFAR4 Q5NUL3 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346751 0.91 ALDH1A1 (0.63) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL9263805 0.89 NPC1 (0.67) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL1680843 0.86 NPC1 (0.71) ALDH1A1HTTFFAR1NPC1RAB9A
SCHEMBL5108159 0.85 NPC1 (0.69) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL241141 0.85 ALDH1A1 (0.58) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL23447430 0.84 NPC1 (0.57) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL3281978 0.84 FAAH (0.58) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL28397858 0.84 ALDH1A1 (0.56) ALDH1A1HTTNPC1RAB9AEPHX1
SCHEMBL17863575 0.82 MMP13 (0.58) ALDH1A1HTTFFAR1NPC1RAB9A
SCHEMBL17552096 0.82 NPC1 (0.69) ALDH1A1HTTNPC1RAB9AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 ALDH1A1 1677/4885HTT 4818/4885FFAR1 3313/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD ALDH1A1 1926/4885HTT 3374/4885FFAR1 3270/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 ALDH1A1 1459/4885HTT 4819/4885FFAR1 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.